Page 14 of 14
When BRCA1/2 genetic susceptibility testing was introduced in the clinic in the mid-nineties, the "Huntington protocol" was used in the counselling of individuals applying for genetic testing. This protocol inclu...
Citation: Hereditary Cancer in Clinical Practice 2004 2:19
Citation: Hereditary Cancer in Clinical Practice 2004 2:17
Options for the prevention of hereditary breast and ovarian cancer include screening, preventive surgery and chemoprevention. Screening studies with magnetic resonance imaging of the breast are promising but t...
Citation: Hereditary Cancer in Clinical Practice 2004 2:5
This paper highlights the need for carriers to be followed up by health professionals who understand the complexities of the BRCA syndrome. A BRCA carrier clinic has been established in London and regular follow ...
Citation: Hereditary Cancer in Clinical Practice 2004 2:77
Mutations in BRCA1 account for the majority of familial aggregations of early onset breast and ovarian cancer (~70%) and about 1/5 of all early onset breast cancer families; in contrast, mutations in BRCA2 accoun...
Citation: Hereditary Cancer in Clinical Practice 2004 2:37
The aim of the study is to evaluate the incidence and phenotype - genotype characteristics of hereditary colorectal cancer syndromes in Latvia in order to develop the basis of clinical management for patients ...
Citation: Hereditary Cancer in Clinical Practice 2003 1:49
Denaturing high performance liquid chromatography is a relatively new method by which heteroduplex structures formed during the PCR amplification of heterozygote samples can be rapidly identified. The use of t...
Citation: Hereditary Cancer in Clinical Practice 2003 1:39
The criteria for the diagnosis of HNPCC established by the ICG-HNPCC are very restrictive as they do not allow for the diagnosis of a large number of "suspected HNPCC" cases - these are families which do no fu...
Citation: Hereditary Cancer in Clinical Practice 2003 1:34
In addition to a relatively small number of well known hereditary cancer syndromes, hundreds of presumed or proven hereditary disorders have been observed to manifest cancer as a characteristic feature or as a...
Citation: Hereditary Cancer in Clinical Practice 2003 1:31
There have been significant advances in our knowledge about the molecular changes that precede and accompany the development of inherited predispositions to colorectal cancer. In this review the clinical relat...
Citation: Hereditary Cancer in Clinical Practice 2003 1:19
HNPCC (Lynch syndrome) is the most common form of hereditary colorectal cancer (CRC), wherein it accounts for between 2-7 percent of the total CRC burden. When considering the large number of extracolonic canc...
Citation: Hereditary Cancer in Clinical Practice 2003 1:7
Speed
86 days to first decision for reviewed manuscripts only
70 days to first decision for all manuscripts
131 days from submission to acceptance
15 days from acceptance to publication
Citation Impact
2.237 - 2-year Impact Factor
2.163 - 5-year Impact Factor
0.820 - Source Normalized Impact per Paper (SNIP)
0.839 - SCImago Journal Rank (SJR)
Usage
163,540 Downloads
91 Altmetric Mentions
Hereditary Cancer in Clinical Practice
